Expression of p63 in anaplastic large cell lymphoma but not in classical Hodgkin's lymphoma

Human Pathology

Volumn 39, Issue 10, 2008, Pages 1505-1510

  Gualco, Gabriela ^a   Weiss, Lawrence M ^b   Bacchi, Carlos E ^a  

^a Consultoria em Patologia ^*  (Brazil)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Anaplastic large cell lymphoma; Hodgkin's lymphoma; Immunohistochemistry; p63; Tissue microarray

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; PROTEIN P63;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER DIAGNOSIS; CHILD; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROTEIN-TYROSINE KINASES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 50649109407     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.02.016     Document Type: Article

References (28)

1. Flores E.R. The roles of p63 in cancer. Cell Cycle 6 (2007) 300-304
2. Hedvat C.V., Teruya-Feldstein J., Puig P., et al. Expression of p63 in diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol 13 (2005) 237-242
3. Di Como C.J., Urist M.J., Babayan I., et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8 (2002) 494-501
4. Nylander K., Vojtesek B., Nenutil R., et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 198 (2002) 417-427
5. Yamaguchi H., Inokuchi K., Tarusawa M., et al. Mutation of P51A/TAP63 g gene is associated with blastic crisis in chronic myeloid leukemia. Exp Hematol 28 (2000) 76
6. Preudhomme C., and Fenaux P. p53 and hematologic malignancies. Pathol Biol (Paris) 45 (1997) 898-908
7. Vigano M.A., and Mantovani R. Hitting the numbers: the emerging network of p63 targets. Cell Cycle 6 (2007) 233-239
8. Finlan L.E., and Hupp T.R. p63: the phantom of the tumor suppressor. Cell Cycle 6 (2007) 1062-1071
9. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon 230-235
10. Vassallo J., Lamant L., Brugiers L., et al. ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's disease. Am J Surg Pathol 30 (2006) 223-229
11. Medeiros L.J., and Elenitoba-Johnson S.J. Anaplastic large cell lymphoma. Am J Clin Pathol 127 (2007) 707-722
12. Tamaru J., Tokuhira M., Nittsu N., et al. Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma. Leuk Lymphoma 48 (2007) 1127-1138
13. Stein H., Mason D.Y., Gerdes J., et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66 (1985) 848-858
14. Park Ch K., and Oh Y.H. Expression of p63 in reactive hyperplasias and malignant lymphomas. J Korean Med Sci 20 (2005) 752-758
15. Willenbrock K., Kuppes R., Renné C., et al. Common features and differences in the trancriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Haematologica 91 (2006) 596-604
16. Nascimento A., Pinkus J., and Pinkus G. Clusterin, a marker for anaplastic large cell lymphoma. Am J Clin Pathol 121 (2004) 709-717
17. Saffer H., Wahed A., Rassidakis G.Z., and Medeiros L.J. Clusterin expression in malignant lymphomas: a survey of 266 cases. Mod Pathol 15 (2002) 1221-1226
18. Pinkus G.S., Pinkus J.L., Langhoff E., et al. Fascin, a sensitive new marker for Reed-Sternberg cells of Hodgkin's disease. Evidence for a dendritic or B cell derivation?. Am J Pathol 150 (1997) 543-562
19. Fan G., Kotylo P., Neiman R.S., and Braziel R.M. Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease. Am J Clin Pathol 119 (2003) 199-204
20. Bakshi N.A., Finn W.G., Schnitzer B., Valdez R., and Ross C.W. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma. Arch Pathol Lab Med 131 (2007) 742-747
21. Mhawech-Fauceglia P., Saxena R., Zhang S., et al. Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis. J Clin Pathol 60 (2007) 709-714
22. McCune R.C., Syrbu S.I., and Vasef M.A. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays. Mod Pathol 19 (2006) 1010-1018
23. Yang A., Kaghad M., Wang Y., et al. p63 and p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2 (1998) 305-316
24. Urist M.J., Di Como C.J., Lu M.L., et al. Loss of p63 expression is associated with tumor progression in bladder cancer. Am J Pathol 161 (2002) 1199-1206
25. Massion P.P., Taflan P.M., Jamshedur Rahman S.M., et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 63 (2003) 7113-7121
26. Corn P.G., Kuerbitz S.J., van Noesel M.M., et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5¢ CpG island methylation. Cancer Res 59 (1999) 3352-3356
27. Novak U., Grob T.J., Baskaynak G., et al. Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. Ann Oncol 12 (2001) 981-986
28. Zigeuner R., Tsybrovsky O., Raschek M., Rehak P., Lipsky K., and Langner C. Prognostic impact of p63 and p53 in upper urinary tract transitional cell carcinoma. Urology 63 (2004) 1079-1083